Covered recipient · General Payments record
LIXIN LIAO
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,012.54
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $296.04 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $79.40 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $53.34 | 2 |
| Incyte Corporation | $48.23 | 2 |
| ARRAY BIOPHARMA INC | $45.72 | 2 |
| Celgene Corporation | $24.97 | 1 |
| Genentech USA, Inc. | $22.74 | 1 |
| GlaxoSmithKline, LLC. | $21.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC | $18.36 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132134959 | CMS |
| ARRAY BIOPHARMA INC | $27.36 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131261942 | CMS |
| Celgene Corporation | $24.97 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101115144 | CMS |
| Genentech USA, Inc. | $22.74 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133055371 | CMS |
| GlaxoSmithKline, LLC. | $21.64 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116424771 | CMS |
| Incyte Corporation | $20.73 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141305545 | CMS |
| Incyte Corporation | $27.50 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141307481 | CMS |
| Lilly USA, LLC | $19.71 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135155769 | CMS |
| Lilly USA, LLC | $28.75 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135146432 | CMS |
| Lilly USA, LLC | $30.94 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135092787 | CMS |
| Novartis Pharmaceuticals Corporation | $23.35 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087109606 | CMS |
| Novartis Pharmaceuticals Corporation | $29.99 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087109618 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.